Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
about
Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy.The role of focal therapy in the management of localised prostate cancer: a systematic review.High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis.Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancerHigh-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapyFocal cryotherapy of localized prostate cancer: a systematic review of the literature.Therapeutic Ultrasound and Prostate Cancer.Minimally invasive ablative therapies for definitive treatment of localized prostate cancer in the primary setting.High-intensity focused ultrasound for the treatment of prostate cancer: A prospective trial with long-term follow-up.Focal therapy will be the next step on prostate cancer management? | Opinion: No.Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.[High intensity focused ultrasound (HIFU) : Importance in the treatment of prostate cancer].Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer.Seven years of experience with high-intensity focused ultrasound for prostate cancer: advantages and limitations.
P2860
Q33773593-BCF729C8-F135-4400-AB93-AE55C56BEC0FQ34250616-2A50164C-DEB2-4618-8638-5FB33FA26116Q34266167-C69EE1CC-0B3D-4CD0-ACBE-550A33497166Q36017399-6290807A-B4E9-4547-B49E-ADC695819E3CQ36246724-D3CCD88D-3852-4987-9469-5C504FE7EE53Q37603749-CA98198F-243B-411E-B7F7-B856DAE5E2B4Q38264786-29F059D9-B1C0-4468-8CF5-7EACEAB88297Q38745164-09A5F566-A0D8-48D4-A147-C83DDC573C06Q39103527-1AC1F4D2-4F66-4890-A496-165A65A9212DQ41716816-3F3F904D-44F6-411F-AE66-7D2B92D0540AQ47160559-1C8E6724-0EEB-46F8-BEDF-A0BB9ACE0B74Q47212709-2E75DAB6-4A82-43DC-A223-B58BE5A1BBD1Q50239426-1B1F921E-720C-4254-98BE-A87BF613AF94Q50243127-121BE785-F78D-4212-8271-3FB7B3339C73Q50245479-C4D1B98B-6168-4C02-A3BB-779A24BCCCB8
P2860
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Correlation of prostate-specif ...... analysis from the @-Registry.
@en
Correlation of prostate-specif ...... analysis from the @-Registry.
@nl
type
label
Correlation of prostate-specif ...... analysis from the @-Registry.
@en
Correlation of prostate-specif ...... analysis from the @-Registry.
@nl
prefLabel
Correlation of prostate-specif ...... analysis from the @-Registry.
@en
Correlation of prostate-specif ...... analysis from the @-Registry.
@nl
P2093
P2860
P1433
P1476
Correlation of prostate-specif ...... analysis from the @-Registry.
@en
P2093
Andreas Blana
Cary N Robertson
Francois J Murat
Giario N Conti
Gilles Pasticier
John F Ward
Roman Ganzer
Stefan Thuroff
Stephen C W Brown
Wolf F Wieland
P2860
P304
P356
10.1111/J.1464-410X.2011.10091.X
P433
P577
2011-02-18T00:00:00Z